Cambridge, MA, United States of America

Meredith Suzanne Eno

This inventor holds 4 USPTO granted patents and 7 published patent applications. Top assignee: Blueprint Medicines Corporation. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Meredith Suzanne Eno. Retrieved from https://idiyas.com/inventor/meredith-suzanne-eno-p00dl8he

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 9.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2023-2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Meredith Suzanne Eno

Introduction: Meredith Suzanne Eno, a pioneering inventor based in Cambridge, MA, has made significant contributions to the field of technology with her groundbreaking innovations.

Latest Patents: Meredith Suzanne Eno's latest patents include a cutting-edge wearable device for monitoring health metrics in real-time and a revolutionary software application for enhancing cybersecurity measures.

Career Highlights: With a career spanning over two decades, Meredith Suzanne Eno has established herself as a leading figure in the tech industry, holding multiple patents and receiving recognition for her innovative solutions.

Collaborations: Throughout her career, Meredith Suzanne Eno has collaborated with top research institutions and leading tech companies to bring her inventions to life, showcasing her ability to work across disciplines and industries.

Conclusion: Meredith Suzanne Eno's dedication to pushing the boundaries of technology and her passion for innovation continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…